Table 3 Cardiac Magnetic Resonance Imaging Outcomes in Study Population

IS T2, ms

57.9 ± 7.9

52.1 ± 6.3

0.022

39.5 ± 3.0

40.6 ± 2.8

0.517

RS T2, ms

41.9 ± 2.7

42.4 ± 2.8

0.552

39.1 ± 2.9

39.6 ± 2.7

0.612

IS EDWT, mm

11.4 ± 2.2

9.3 ± 1.6

0.013

4.0 ± 1.1

5.7 ± 1.0

0.008

RS EDWT, mm

7.0 ± 1.4

6.9 ± 1.3

0.883

8.3 ± 1.3

7.8 ± 1.2

0.443

IS T2*, ms

29.3 ± 9.4

37.8 ± 7.0

0.007

33.9 ± 4.9

35.7 ± 5.7

0.435

RS T2*, ms

37.1 ± 3.4

38.0 ± 3.1

0.662

38.0 ± 3.7

38.2 ± 4.4

0.712

Hemorrhage, % of myocardium

11.6 ± 6.8

7.1 ± 3.8

0.02

-

-

-

Hemorrhage, n (%)

13 (52.0)

7 (20.0)

0.02

-

-

-

MVO, % of myocardium

6.7 ± 4.2

3.4 +3.1

0.003

-

-

-

MVO, n (%)

22 (88.0)

19 (54.3)

0.013

-

-

-

Infarct Size, % of myocardium

27.3 ± 9.1

19.8 ± 8.2

0.001

16.8 ± 8.7

13.8 ± 4.8

0.022

LVEDVI, ml/mm2

68.6 ± 17.6

70.4 ± 11.9

0.717

91.9 ± 21.1

68.3 ± 8.7

0.013

LVESVI, ml/mm2

37.1 ± 12.3

38.1 ± 9.9

0.873

52.1 ± 16.9

32.4 ± 5.3

0.008

LVSVI, ml/mm2

30.4 ± 9.5

32.7 ± 4.3

0.546

40.4 ± 11.2

35.8 ± 8.1

0.301

LVEF, %

44.7 ± 8.1

46.4 ± 5.9

0.392

46.8 ± 10.5

53.8 ± 7.7

0.11

IS-SWT, %

4.9 ± 24.8

-2.9 ± 18.3

0.224

3.5 ± 19.5

74.8 ± 58.5

0.003